Trial Profile
Coenzyme Q10 as adjunctive treatment of chronic heart failure: a randomised, double-blind, multicentre trial with focus on SYMptoms, BIOmarker status (Brain-Natriuretic Peptide [BNP]), and long-term outcome (hospitalisations/mortality)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms Q-SYMBIO
- Sponsors Pharma Nord
- 15 Aug 2011 New trial record